Abstract
1α,25-Dihydroxyvitamin D3 [1α,25(OH)2D3] has been shown to generate biological responses via both genomic and nongenomic pathways. In the nongenomic process, 1α,25(OH)2D3 stimulates the rapid transport of Ca2+ across the chick intestinal epithelial cell, a process termed transcaltachia. In previous studies, the involvement of Ca2+-channels, protein kinase C, and cAMP-dependent kinase in the 1α,25(OH)2D3 stimulated transcaltachic response have been implicated. To further characterize the elements involved in mediating the transcaltachic effect, H7, an inhibitor of protein kinase C, U73122, an inhibitor of phospholipase C, and mastoparan, an activator of G-proteins, were employed. Both H7 and U73122 suppressed 1α,25(OH)2D3 stimulated intestinal Ca2+ transport. Mastoparan was found to mimic the effect of 1α,25(OH)2D3 to stimulate transcaltachia. Collectively, these results suggest that 1α,25(OH)2D3 activations of G-proteins, phospholipase C and protein kinases are essential steps in the rapid stimulation of intestinal Ca2+ transport.
Similar content being viewed by others
References
Baran, D. T., Sorensen, A. M., and Honeyman, R. W. (1988).J. Bone Min. Res. 3, 593–600.
Barsony, J., and Marx, S. J. (1991).Proc. Natl. Acad. Sci. USA 88, 1436–1440
Bhatia, M., Kirkland, J. B., and Meckling-Gill, K. A. (1995).J. Biol. Chem. 270/27, 15,962–15,965.
Birnbaumer, L., Abramowitz, J., and Brown, A. M. (1990).Biochim. Biophys. Acta 1031, 163–224.
Bleasdale, J. E., Bundy, G. L., Bunting, S., Fitzpatrick, F. A., Huff, R. M., Sun, F. F., and Pike, J. E. (1989). In:Advances in Prostaglandin, Thromboxane and Leukotriene Research, vol. 19. Samuelsson, B., Wjong, P. Y.-K., and Sun, F. F. (eds.). Raven: New York, pp. 590.
Bourdeau, A., Atmani, F., Grosse, B., and Lieberherr, M. (1990).Endocrinology 127, 2738–2793.
Caffrey, J. M., and Farach-Carson, M. C. (1989).J. Biol. Chem. 264, 20,265–20,274.
Civitelli, R., Kim, Y. S., Gunsten, S. L., Fujimori, A., Huskey, M., Avioli, L. V., and Hruska, K. A. (1990).Endocrinology 127, 2253–2262.
de Boland, A. R. and Norman, A. W. (1990a).Endocrinology 127, 39–45.
de Boland, A. R., and Norman, A. W. (1990b).Biochem. Biophys. Res. Commun. 166, 217–220.
Desai, S. S., Appel, M. C., and Baran, D. T. (1986).J. Bone Min. Res. 1, 497–501.
De Waard, M., Seagar, M., Feltz, A., and Couraud, F. (1992).Neuron 9, 497–503.
Dick, I. M., Retallack, R., and Prince, R. L. (1990).Am. J. Physiol. 259, E272-E277.
Dohlman, H. G., Caron, M. G., and Lefkowitz, R. J. (1987).Biochemistry 26, 2657–2664.
Edelman, A., Garabedian, M., and Anagnostopoulos, T. (1986).J. Membrane Biol. 90, 137–143.
Gusovsky, F., Soergel, D. G., and Daly, J. W. (1991).Eur. J. Pharmacol. 206, 309–314.
Hermenegildo, C., Felipo, V., Minana, M. A., Romero, F. J., and Grisolia, S. (1993).Diabetes 24, 257–262.
Higashijima, T., Uzu, S., Nakajima, T., and Ross, M. (1988).J. Biol. Chem. 263, 6491–6494.
Kikuchi, A., Kozawa, O., Kaibuchi, K., Katada, T., Ui, M., and Takai, Y. (1986).J. Biol. Chem. 261, 11,558–11,562.
Kurnic, B. R. C., Huskey, M., and Hruska, K. A. (1987).Biochem. Biophys. Acta 917, 81–85.
Mezzetti, G., Monti, M. G., Casolo, L. P., and Moruzzi, M. S. (1988).Endocrinology 122, 389–394.
Minghetti, P. P., and Norman, A. W. (1988).FASEB J. 2, 3043–3053.
Nemere, I. and Norman, A. W. (1987).J. Bone Min. Res. 2, 99–107.
Nemere, I., Leathers, V., and Norman, A. W. (1986).J. Biol. Chem. 261, 16,106–16,114.
Nemere, I., Yoshimoto, Y., and Norman, A. W. (1984).Endocrinology 115, 1476–1483.
Nemere, I., Dormanen, M. C., Hammond, M. W., Okamura, W. H., and Norman, A. W. (1994).J. Biol. Chem. 269, 23,750–23,756.
Norman, A. W., Okamura, W. H., Farach-Carson, C., Allewaert, K., Branisteanu, D., Nemere, I., Muralidharan, K. R., and Bouillon, R. (1993).J. Biol. Chem. 268/19, 13,811–13,819.
Raya, A., Gallego, J., Hermenegildo, C., Puertas, F. J., Romero, F. J., Felipo, V., Minana, M. D., Grisolia, F. J., and Roma, J. (1992).Toxicology 75, 249–256.
Smith, R. J., San, L. M., Justen, J. M., Bundy, G. L., Bala, G. A., and Beasdale, J. (1990).J. Pharmacol. Exp. Ther. 253, 688–697.
Thompson, N. T., Bonser, R. W., and Garland, L. G. (1991).Trends Pharmacol. Sci. 12, 404–408.
Tien, X. Y., Brasitus, T. A., Qasawa, B. M., Norman, A. W., and Sitrin, M. D. (1993).Am. J. Physiol. 265, G143-G148.
Wali, R. K., Baum, C. L., Sitrin, M. D., and Brasitus, A. (1990).J. Clin. Invest. 85, 1296–1303.
Wallace, M. A. and Carter, H. R. (1989).Biochim. Biophys. Acta 1006, 311–316.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhou, LX., Norman, A.W. Characterization of the second messengers involved in 1α,25-dihydroxyvitamin D3 stimulated intestinal calcium absorption (transcaltachia). Endocr 5, 47–50 (1996). https://doi.org/10.1007/BF02738655
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02738655